skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzimidazoles > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
organooxygen compound > oxacycle > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzoxazine > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > thiazolidines > thiazolidinone > n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide

Preferred term

n-[(1s)-1-(1h-benzimidazol-2-yl)-2-/{4-[(5s)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl/}ethyl]-4-methyl-3,4-dihydro-2h-1,4-benzoxazine-7-sulfonamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

subset

  • 1_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:43438

Download this concept:

RDF/XML TURTLE JSON-LD